Lilly Pulitzer is serving up a Valentine’s Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking ...

Lilly Pulitzer’s treasured Sunshine Sale is back with splurge-worthy discounts and new styles perfect for the winter or ...

A long-sleeve blouse is a smart closet staple for polished outfits in a pinch — especially when it’s as cute as this one. Hundreds of shop ...

Telnaes, who won a Pulitzer Prize for Editorial Cartooning in 2001, has long been an advocate for free speech and editorial cartoons as a tool for civic debate. She serves on the advisory board ...

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...

Senior equity analysts at StockNews.com upgraded Eli Lilly (LLY, Financial) stock from 'hold' to 'buy' as its stock has shifted positively. Analysts say the upgrade is a sign of increased ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Novo and Lilly have both been on a manufacturing expansion tear in 2024, lining up multiple high-profile production projects around the world. To name just a few investments, Novo has blueprinted ...

Art Spiegelman, whose graphic novel about the Holocaust won the Pulitzer Prize, now plans to write one about the war in Gaza — though he knows it will inevitably be controversial. “I’ve ...

Eli Lilly has been riding the weight-loss drug wave. The company's weight-loss drugs have been shown to be more effective than rival Ozempic. The stock currently trades at an attractive valuation.